Scope
Reference
DACPM2025-30
Description
Procurement of MIDOSTAURIN 25MG CAPSULES, 56 capsules, pack
Contract 1. MIDOSTAURIN 25MG CAPSULES, 56 capsules, pack
Supplier
Contract value
- £300,000 excluding VAT
- £300,000 including VAT
Above the relevant threshold
Earliest date the contract will be signed
30 June 2025
Contract dates (estimated)
- 1 July 2025 to 30 June 2027
- 2 years
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKN - Northern Ireland
Other information
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Direct award
Direct award justification
Single supplier - intellectual property or exclusive rights
These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement.
Supplier
NOVARTIS PHARMACEUTICALS UK LIMITED
- Companies House: 00119006
- Public Procurement Organisation Number: PJTX-5182-QVLR
2nd Floor, The Westworks Building White City Place
London
W12 7FQ
United Kingdom
Email: commercial.pricing@novartis.com
Website: https://www.novartis.com/uk-en/
Region: UKI33 - Kensington & Chelsea and Hammersmith & Fulham
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Contract 1. MIDOSTAURIN 25MG CAPSULES, 56 capsules, pack
Contracting authority
Belfast Health & Social Care Trust
- Public Procurement Organisation Number: PLQJ-5727-JCLR
Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital
Belfast
BT12 6BA
United Kingdom
Region: UKN06 - Belfast
Organisation type: Public authority - central government
Devolved regulations that apply: Northern Ireland